difference between tirzepatide vs semaglutide Semaglutide: 2026 Clinical Comparison Tirzepatide vs. Ozempic: Comparing Diabetes

When fatigue occurs in patients taking GLP-1 receptor agonists, it may be directly related to the medication, secondary to the physiological changes these drugs induce (such as reduced caloric intake or altered glucose metabolism), or entirely unrelated to the treatment

The intensity of nausea varies widely depending on your starting dose, metabolism, and individual GLP-1 receptor sensitivity

What Im afraid of happening at the end of this week when the deadline hits is that patients and providers wont have access to the medications they need, and they will be financially impacted as they move forward because of this. The Outsourcing Facilities Association filed lawsuits against the FDA about the sudden removal of tirzepatide and semaglutide from the drug shortage list, but the judge in both cases ruled to allow the FDA plan to block compounded products to continue

You might be wondering, How does this tie into what Im experiencing? Again, GLP-1 treatments are not prescribed specifically for menopause, but they can indirectly alleviate some symptoms associated with menopause by helping you lose weight